Tandem Diabetes Care, Inc. (TNDM) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $70.00K; Additional Paid in Capital, Common StockUSD $1.42B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $6.40M; Retained Earnings (Accumulated Deficit)USD $-1.29B.
- 2026-03-31: Common Stock, Value, IssuedUSD $69.00K; Additional Paid in Capital, Common StockUSD $1.40B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $5.04M; Retained Earnings (Accumulated Deficit)USD $-1.27B.
- 2025-12-31: Common Stock, Value, IssuedUSD $68.00K; Additional Paid in Capital, Common StockUSD $1.40B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $5.59M; Retained Earnings (Accumulated Deficit)USD $-1.25B.
- 2025-09-30: Common Stock, Value, IssuedUSD $68.00K; Additional Paid in Capital, Common StockUSD $1.38B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $5.17M; Retained Earnings (Accumulated Deficit)USD $-1.25B.
Tandem Diabetes Care, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Additional Paid in Capital USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $70.00K | $1.42B | $6.40M | $-1.29B | $130.39M | 3 month · $15.64M 6 month · $30.81M | (m) | (m) | (m) | (m) |
| 2026-03-31 | $69.00K | $1.40B | $5.04M | $-1.27B | $132.40M | 3 month · $15.17M | (m) | (m) | (m) | (m) |
| 2025-12-31 | $68.00K | $1.40B | $5.59M | $-1.25B | $155.17M | 12 month · $91.85M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $68.00K | $1.38B | $5.17M | $-1.25B | $132.97M | 3 month · $20.99M 9 month · $72.08M | (m) | (m) | (m) | (m) |
| 2025-06-30 | $68.00K | $1.36B | $3.75M | $-1.23B | $133.28M | 3 month · $25.68M 6 month · $51.09M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $67.00K | $1.33B | $75.00K | $-1.18B | $155.29M | 3 month · $25.41M | (m) | (m) | (m) | (m) |
| 2024-12-31 | $66.00K | $1.31B | $-1.95M | $-1.05B | $263.10M | 12 month · $101.17M | (m) | (m) | (m) | (m) |
| 2024-09-30 | $66.00K | $1.28B | $3.87M | $-1.05B | $237.71M | 3 month · $26.48M 9 month · $73.02M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $65.00K | $1.26B | $-1.25M | $-1.03B | $233.88M | 3 month · $24.95M 6 month · $46.54M | (m) | (m) | (m) | (m) |
| 2024-03-31 | $65.00K | $1.24B | $-935.00K | $-994.51M | $243.06M | 3 month · $21.59M | (m) | (m) | (m) | (m) |
| 2023-12-31 | $66.00K | $1.26B | $1.37M | $-951.80M | $313.63M | 12 month · $88.93M | (m) | (m) | (m) | (m) |
| 2023-09-30 | $65.00K | $1.24B | $-2.21M | $-921.80M | $314.00M | 3 month · $20.58M 9 month · $65.48M | (m) | (m) | (m) | (m) |
| 2023-06-30 | $65.00K | $1.22B | $-1.19M | $-888.84M | $329.23M | 3 month · $23.41M 6 month · $44.91M | (m) | (m) | (m) | (m) |
| 2023-03-31 | $65.00K | $1.19B | $-93.00K | $-853.06M | $338.75M | 3 month · $21.50M | (m) | (m) | (m) | (m) |
| 2022-12-31 | $65.00K | $1.17B | $-1.82M | $-729.19M | $439.95M | 12 month · $85.08M | (m) | (m) | (m) | (m) |
| 2022-09-30 | $64.00K | $1.14B | $-5.06M | $-713.34M | $421.82M | 3 month · $22.36M 9 month · $60.45M | (m) | (m) | (m) | (m) |
| 2022-06-30 | $64.00K | $1.12B | $-4.28M | $-664.37M | $449.58M | 3 month · $20.16M 6 month · $38.09M | (m) | (m) | (m) | (m) |
| 2022-03-31 | $64.00K | $1.09B | $-3.06M | $-649.31M | $437.38M | 3 month · $17.93M | (m) | (m) | (m) | (m) |
| 2021-12-31 | $64.00K | $1.07B | $-616.00K | $-634.60M | $433.11M | 12 month · $61.09M | (m) | (m) | (m) | (m) |
| 2021-09-30 | $63.00K | $1.03B | $14.00K | $-645.40M | $389.65M | 3 month · $15.87M 9 month · $44.01M | (m) | (m) | (m) | (m) |
| 2021-06-30 | $63.00K | $997.19M | $29.00K | $-651.20M | $346.08M | 3 month · $15.12M 6 month · $28.13M | (m) | (m) | (m) | (m) |
| 2021-03-31 | $63.00K | $968.45M | $106.00K | $-655.21M | $313.41M | 3 month · $13.01M | (m) | (m) | (m) | (m) |
| 2020-12-31 | $62.00K | $1.03B | $220.00K | $-659.21M | $366.31M | 12 month · $57.73M | (m) | 12 month · $85.80M | 12 month · $34.07M | (m) |
| 2020-09-30 | $62.00K | $1.00B | $190.00K | $-676.21M | $326.54M | 3 month · $12.30M 9 month · $44.52M | (m) | 9 month · $85.80M | 9 month · $34.07M | (m) |
| 2020-06-30 | $61.00K | $934.40M | $43.00K | $-666.80M | $267.70M | 3 month · $16.41M 6 month · $32.22M | (m) | 3 month · $85.80M 6 month · $85.80M | 3 month · $34.07M 6 month · $34.07M | (m) |
| 2020-03-31 | $60.00K | $847.06M | $-245.00K | $-639.70M | $207.18M | 3 month · $15.81M | (m) | (m) | (m) | (m) |
| 2019-12-31 | $59.00K | $819.63M | $122.00K | $-624.83M | $194.98M | 12 month · $58.62M | (m) | (m) | (m) | (m) |
| 2019-09-30 | $59.00K | $794.32M | $91.00K | $-627.48M | $166.99M | 3 month · $17.57M 9 month · $39.74M | (m) | (m) | (m) | (m) |
| 2019-06-30 | $58.00K | $769.70M | $162.00K | $-624.58M | $145.34M | 3 month · $12.41M 6 month · $22.16M | (m) | (m) | (m) | (m) |
| 2019-03-31 | $58.00K | $743.93M | $41.00K | $-623.07M | $120.96M | 3 month · $9.75M | (m) | (m) | (m) | (m) |
| 2018-12-31 | $57.00K | $731.31M | $-13.00K | $-600.08M | $131.28M | 12 month · $24.00M | (m) | (m) | (m) | (m) |
| 2018-09-30 | $57.00K | $719.15M | $-13.00K | $-603.76M | $115.43M | 3 month · $10.00M 9 month · $13.95M | (m) | (m) | (m) | (m) |
| 2018-06-30 | $53.00K | $595.46M | $6.00K | $-569.52M | $26.00M | 3 month · $2.81M 6 month · $3.95M | (m) | (m) | (m) | (m) |
| 2018-03-31 | $47.00K | $521.96M | (m) | $-510.16M | $11.85M | 3 month · $1.13M | (m) | (m) | (m) | (m) |
| 2017-12-31 | $10.00K | $448.45M | (m) | $-477.61M | $-29.15M | 12 month · $12.56M | (m) | (m) | (m) | 12 month · $3.33M |
| 2017-09-30 | $55.00K | $438.19M | (m) | $-466.21M | $-27.96M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $50.00K | $431.84M | (m) | $-450.17M | $-18.28M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $50.00K | $426.45M | (m) | $-428.37M | $-1.87M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $3.00K | $398.65M | $-1.00K | $-404.58M | $-5.93M | 12 month · $11.75M | (m) | (m) | (m) | (m) |
| 2016-09-30 | $31.00K | $394.93M | $-3.00K | $-389.76M | $5.20M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $31.00K | $391.98M | $3.00K | $-359.94M | $32.07M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $30.00K | $387.49M | $40.00K | $-341.62M | $45.94M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $30.00K | $384.55M | $20.00K | $-321.13M | $63.47M | 12 month · $13.05M | (m) | (m) | (m) | (m) |
| 2015-09-30 | $30.00K | $380.21M | $32.00K | $-309.04M | $71.23M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $30.00K | $377.14M | $37.00K | $-289.46M | $87.75M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $30.00K | $372.10M | $39.00K | $-269.92M | $102.25M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $24.00K | $303.25M | $8.00K | $-248.72M | $54.57M | 12 month · $14.92M | $303.25M | (m) | (m) | (m) |
| 2014-09-30 | $23.49K | (m) | $18.81K | $-230.25M | $67.48M | (m) | $297.69M | (m) | (m) | (m) |
| 2014-06-30 | $23.45K | (m) | $12.28K | $-210.35M | $83.55M | (m) | $293.86M | (m) | (m) | (m) |
| 2014-03-31 | $22.98K | (m) | $13.83K | $-191.15M | $97.26M | (m) | $288.38M | (m) | (m) | (m) |
| 2013-12-31 | $23.00K | (m) | (m) | $-169.19M | $115.54M | 12 month · $4.72M | $284.70M | (m) | (m) | 12 month · $437.00K |
| 2012-12-31 | (m) | (m) | (m) | (m) | $-106.05M | 12 month · $246.00K | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | $-71.30M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |